Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Syner-G Biopharma Group Names Neil Butera Chief Commercial Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Syner-G Biopharma Group Names Neil Butera Chief Commercial Officer

Brings depth and breadth of biotech experience to oversee continued company growth.

By: Anthony Vecchione

Syner-G BioPharma Group, a provider of integrated pharmaceutical science and regulatory consulting services to pharmaceutical and biotechnology clients, appointed Neil Butera chief commercial officer.

“We are thrilled to have Neil join the Syner-G team,” said Ron Kraus, CEO, Syner-G. “His proven commercial experience in the bio-tech industry is an invaluable asset to the current leadership team. We look forward to seeing the unique ways he will propel our services while contributing to our culture of guiding clients to a healthier tomorrow.”

Butera’s previous experience includes 15 years at Parexel where he held business development roles within the clinical research and regulatory Consulting business units before becoming the executive director, global head of inside sales for Parexel’s biotech division.

According to the company, Buter’s organization helped Parexel Biotech secure over $1 billion in new business awards.

Prior to his work at Parexel, Butera was director of business development for Ockham Development Group.

“I am honored to be chosen as the new chief commercial officer for Syner-G,” said Butera. “It is exciting to be a part of this innovative company whose services underpin the successful development of lifesaving therapies across the biopharma industry.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters